Appili Therapeutics Inc (APLI) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.00x

Appili Therapeutics Inc (APLI) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting CA$2.36K (capex CA$2.36K ) from operating cash flow of CA$1.03 Million. See how much free cash does Appili Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

CA$2.36K

Capex + Investments

Operating Cash Flow

CA$1.03 Million

CAD

Capital Expenditures

CA$2.36K

CAD

Appili Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for Appili Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Appili Therapeutics Inc operating cash flow efficiency.

Annual Cash Flow Reinvestment Rate for Appili Therapeutics Inc (2025–2025)

Year-by-year capital reinvestment analysis for Appili Therapeutics Inc. See APLI free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2025	0.01x	CA$4.72K	CA$868.82K	CA$2.36K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow